Diabetic ketoacidosis (DKA) requires emergency treatment in a hospital, typically involving three simultaneous interventions: intravenous fluids to correct severe dehydration, insulin to stop the dangerous buildup of acids in the blood, and electrolyte replacement to keep the heart and muscles functioning safely. Most people spend one to three days in the hospital, with the most intensive monitoring and treatment happening in the first 12 to 24 hours.
DKA develops when the body doesn’t have enough insulin to use glucose for energy and starts breaking down fat at a dangerous rate instead. This floods the bloodstream with acids called ketones, which can become life-threatening without prompt treatment. Understanding what happens during treatment can help you or a loved one know what to expect.
Intravenous Fluids Come First
People in DKA are almost always severely dehydrated, sometimes by several liters. High blood sugar causes the kidneys to flush out large amounts of water, and vomiting (a common DKA symptom) makes the deficit worse. Replacing that fluid is the very first step, often starting before insulin is even given.
The initial pace is aggressive: 1 to 3 liters of saline solution in the first hour alone, then roughly a liter per hour for the next few hours. As your fluid levels stabilize, the rate slows to about a liter every four hours. The medical team adjusts the speed and type of fluid based on your sodium levels and how your body is responding. This rapid rehydration alone begins to lower blood sugar and improve circulation, which helps insulin work more effectively once it’s started.
Insulin to Stop Acid Buildup
Insulin is delivered through a continuous IV drip rather than the injections you may be used to at home. A steady drip allows the care team to adjust the dose in real time based on how quickly your blood sugar and acid levels are dropping. The goal isn’t just to lower blood sugar. More importantly, insulin signals the body to stop breaking down fat, which is what produces the dangerous ketones in the first place.
There is one critical safety rule: if your potassium level is too low (below 3.3 mEq per liter), insulin is held until potassium is replaced. Insulin drives potassium into cells, and starting it when levels are already dangerously low can cause heart rhythm problems. This is why blood work happens before the insulin drip begins.
Once blood sugar drops to a certain threshold, the team typically adds a sugar-containing IV fluid alongside the insulin. This might sound counterintuitive, but it prevents blood sugar from crashing while the insulin drip continues doing its real job: clearing ketones and correcting the acid imbalance.
Potassium and Electrolyte Replacement
Potassium is the electrolyte that gets the most attention during DKA treatment, because the condition creates a misleading situation. Blood potassium levels may look normal or even high on the initial lab work, but the body’s total potassium stores are almost always depleted. As insulin and fluids start working, potassium shifts back into cells and blood levels can plummet quickly.
The treatment team follows specific thresholds. If potassium is between 3.3 and 5.2 mEq per liter, replacement is added to the IV fluids alongside insulin. If it’s below 3.3, potassium replacement takes priority and insulin is delayed until levels are safer. This careful balancing act is one of the main reasons DKA requires hospital-level monitoring rather than at-home management.
How Doctors Track Your Progress
During treatment, you can expect frequent blood draws and finger sticks. Blood sugar is checked every one to two hours. A broader panel, including electrolytes, kidney function, acid levels in the blood, and a ketone marker called beta-hydroxybutyrate, is checked every four hours until DKA has resolved.
The 2024 consensus guidelines shifted how resolution is determined. Rather than relying primarily on blood pH or a calculation called the anion gap, the current standard is to track beta-hydroxybutyrate directly, since it measures the actual ketones causing the problem. When ketone levels drop adequately and you’re able to eat and drink, the team begins transitioning you off IV treatment. In hospitals where direct ketone measurement isn’t available, the anion gap remains a reasonable backup marker.
Switching Back to Injections
The transition from an IV insulin drip to subcutaneous (under-the-skin) injections is a step that requires careful timing. If the drip is stopped too soon or the overlap is too short, ketones can rebound quickly and push you back into DKA.
The standard approach is to give a long-acting insulin injection while the IV drip is still running, then continue the drip for about two more hours before discontinuing it. This overlap ensures there’s always insulin circulating while the long-acting injection builds up in your system. You’ll also need to be tolerating food and fluids by mouth before this switch happens. Meal-time insulin doses are added once you start eating again.
DKA With Normal Blood Sugar
A form called euglycemic DKA can occur in people taking a class of diabetes medications known as SGLT2 inhibitors (commonly prescribed drugs for type 2 diabetes that work by causing the kidneys to excrete excess sugar). In these cases, blood sugar may be near-normal even though dangerous ketone levels are present, which can delay diagnosis.
Treatment follows the same principles as standard DKA, with a few key differences. Because blood sugar is already relatively low, a sugar-containing IV fluid (typically a 10% dextrose solution) is needed from the start to prevent hypoglycemia while insulin does its work. The SGLT2 inhibitor is stopped immediately. Perhaps most importantly, the risk of relapsing back into DKA is higher with this form. Patients typically need an additional 24 hours of close monitoring after the DKA appears to have resolved, and the insulin drip should not be discontinued prematurely. Whether to restart the SGLT2 inhibitor afterward is a decision made on a case-by-case basis.
Risks During Treatment
The most serious complication of DKA treatment itself is brain swelling, known as cerebral edema. This is primarily a concern in children and adolescents rather than adults. Symptoms typically appear within the first 12 hours of treatment, though they can occasionally show up before treatment even begins. Children who present with more severe DKA, particularly those with significant acidosis and elevated markers of dehydration, face the highest risk.
Changes in mental status, such as confusion, unusual drowsiness, or irritability that worsens rather than improves during treatment, are the key warning signs. This is one reason pediatric DKA patients are monitored especially closely, with neurological checks alongside the standard blood work.
Other potential complications during treatment include potassium dropping too quickly (which can affect heart rhythm), fluid overload if rehydration is too aggressive, and low blood sugar if insulin dosing outpaces glucose monitoring. The frequent lab checks every one to four hours are specifically designed to catch and correct these problems early.
What Recovery Looks Like
Most people with uncomplicated DKA spend one to two days in the hospital, though severe cases or those with underlying triggers (like a serious infection) may take longer. Once you’ve transitioned to subcutaneous insulin, are eating and drinking normally, and your lab values have stabilized, discharge planning begins.
Before leaving, the care team will work with you to identify what triggered the episode. Common triggers include missed insulin doses, illness or infection, new-onset diabetes (DKA is sometimes the first sign), and in some cases, medication interactions. Understanding your trigger is one of the most important parts of preventing a recurrence, since DKA has a high rate of repeat episodes in people who’ve experienced it once.